Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Urinary Bladder Neoplasms 9Glioblastoma 6Sarcoma 3Glioma 3Brain Neoplasms 3Pancreatic Neoplasms 2Neoplasms 2Astrocytoma 2Urothelial Carcinoma of the Bladder 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Hyperplasia 1Pathologic Complete Response 1Paranasal Sinus Neoplasms 1Oligodendroglioma 1Non-Muscle Invasive Bladder Urothelial Carcinoma 1Non-Muscle Invasive Bladder Neoplasms 1Muscle-invasive Urothelial Cancer of the Bladder 1Melanoma 1Lymphoma, Follicular 1Lung Neoplasms 1Giant Cell Tumor of Bone 1Estrogen Receptor Positive Breast Cancer 1Ependymoma 1Craniopharyngioma 1Carcinoma, Non-Small-Cell Lung 1Alzheimer Disease 1

Interventions

Denosumab 3Zoledronic Acid 2Indocyanine Green 2gentamicin-polymethylmethacrylate bead 1fludarabine 1aldesleukin 1Transurethral Resection of Bladder 1Surgical Procedures, Operative 1Nivolumab 1Methods 1Ipilimumab 1Dasatinib 1Cyclophosphamide 1Curettage 1CTLA-4 Antigen 1Amputation, Surgical 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Giant Cell Tumor of Bone × Transurethral Resection of Bladder × Clear all
NCT07227961 2025-11-13

PROMIS and Mobility Evaluation in Sarcoma Patients

University of Calgary

Recruiting
800 enrolled
Sarcoma

Alzheimer Disease, Sarcoma, Giant Cell Tumor of Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡